Background illustration for clinical trials search

Paid Clinical Trials Wilmington

Discover 265 paid clinical trials in Wilmington, Delaware. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Mechanical Perturbation Training for ACL Injury Prevention

for
Anterior Cruciate Ligament Injury, ACL
Location: Newark DE
Sponsor: University of Delaware

Sex: Female

Age: 15 - 30

Code: NCT03080402

Recruiting

Determinants of Changes in Arterial Load Following Exercise

for
Post-Exercise Hypotension
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 18 - 45

Code: NCT05820243

Recruiting

Dietary Sodium, Oxidative Stress, and Pulsatile Hemodynamics

for
Sodium Excess
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 21 - 45

Code: NCT04233957

Recruiting

Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease

for
Chronic Kidney Disease
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 18+

Code: NCT02364648

Recruiting

Light Therapy Intervention in Individuals With Parkinson's Disease

for
Parkinson Disease
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 50 - 70+

Code: NCT06916260

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Wilmington DE, Philadelphia PA, Baltimore MD,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase 2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Newark DE, Camden NJ, York PA, Hershey PA, Bethesda MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Newark DE, Lancaster PA, Baltimore MD, Hershey PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Newark DE, New Brunswick NJ, Arlington VA, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for
Gastroesophageal Adenocarcinoma
Location: Newark DE, Washington D.C. DC, New York NY, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07069712

Phase 2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Newark DE, Philadelphia PA, West Reading PA,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Newark DE, Camden NJ, Baltimore MD, York PA, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Newark DE, Philadelphia PA, Fountain Hill PA, Towson MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase 3, Recruiting

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

for
Cancer
Location: Paoli PA, Dover DE, Milford DE, Elk Grove Village IL,
Sponsor: N-Power Medicine

Sex: All

Age: 18 - 70+

Code: NCT06877884

Recruiting

An External Control Arm Study in Non-Small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Wynnewood PA, Dover DE, Milford DE, New York NY,
Sponsor: N-Power Medicine

Sex: All

Age: 18+

Code: NCT07174388

Recruiting

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Philadelphia PA, Abington PA, Hershey PA, Edison NJ,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT03907046

Phase 3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Voorhees Township NJ, Moorestown NJ, Dover DE,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase 2, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Voorhees Township NJ, Moorestown NJ, Dover DE,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase 2, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for
Lung Non-Small Cell Carcinoma
Location: Voorhees Township NJ, Moorestown NJ, Dover DE,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06116682

Phase 2, Recruiting

The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature

for
Anxiety Disorders and Symptoms, Fibromyalgia, Arthritis,
Location: Dover DE
Sponsor: Faith A. Richardson

Sex: All

Age: 21 - 70+

Code: NCT05067998

Recruiting